Oct 06, 05
|
| NEW STORY |
| 07:16 ET |
Panacos Announces Pricing of Common Stock Offering
|
|
Sep 28, 05
|
| 07:46 ET |
Panacos Announces Proposed Offering of Common Stock
|
|
Sep 07, 05
|
| 08:57 ET |
Panacos and Leading HIV Clinicians to Discuss PA-457 Clinical Trial Results
|
|
Sep 06, 05
|
| 18:02 ET |
Panacos Files Shelf Registration Statement
|
|
| 13:17 ET |
Panacos to Present at the Bear Stearns 18th Annual Healthcare Conference
|
|
Aug 22, 05
|
| 06:00 ET |
Panacos Drug Candidate PA-457 Shows Potent Antiviral Activity in HIV-infected Patients
|
|
Aug 18, 05
|
| 08:01 ET |
Panacos Appoints Peyton Marshall Executive Vice President and CFO
|
|
| 08:00 ET |
Vitex Completes Corporate Name Change to Panacos Pharmaceuticals, Inc.
|
|
Jul 27, 05
|
| 07:04 ET |
Vitex Reports Second Quarter Results for 2005
|
|
Jul 26, 05
|
| 08:49 ET |
V.I. Technologies Presents Further Analysis of PA-457's Antiviral Activity Following a Single Oral Dose in HIV-infected Patients, at 3rd International AIDS Society Conference
|
|
Jul 22, 05
|
| 12:26 ET |
Vitex to Report Second Quarter 2005 Financial Results
|
|
Jun 30, 05
|
| 10:45 ET |
Vitex Provides Corporate Update Following Annual Shareholders Meeting
|
|
Jun 28, 05
|
| 07:00 ET |
V.I. Technologies to be Added to the New Russell Microcap(TM) Index
|
|
Jun 27, 05
|
| 07:00 ET |
Vitex Announces Webcast of its Annual Shareholders Meeting
|
|
May 24, 05
|
| 07:00 ET |
V.I. Technologies and Collaborators Present Three Studies on the Molecular Target of PA-457, First-in-Class HIV Maturation Inhibitor, at the Cold Spring Harbor Retrovirus Conference
|
|
May 18, 05
|
| 09:30 ET |
Vitex to Present at the Fourth Annual Needham Biotechnology Conference
|
|
May 13, 05
|
| 13:41 ET |
Vitex Files Shelf Registration Statement
|
|
May 11, 05
|
| 07:00 ET |
Vitex Reports First Quarter Results for 2005
|
|
May 09, 05
|
| 09:04 ET |
Vitex Announces Management Change
|
|
May 06, 05
|
| 10:58 ET |
Vitex to Report First Quarter 2005 Financial Results
|
|
Apr 28, 05
|
| 08:02 ET |
Vitex to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference
|
|
Mar 30, 05
|
| 12:42 ET |
Vitex Regains Compliance with Nasdaq Listing Requirements
|
|